Symbol: |
SIRT2
|
Description: |
sirtuin 2 [Source:HGNC Symbol;Acc:10886]
|
Location: |
Chr19:39369197-39390502[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:134
Gene |
Compound |
Gen_sig |
Exp_pattern |
SIRT2 |
4-Benzylidene-2-phenyl-5(4H)-oxazolone |
0.002 |
Down |
SIRT2 |
3-Phenacyliden-5-brom-2-indolinon |
0.023 |
Up |
SIRT2 |
2,4-Pyrimidinediamine, 5-(4-chloro-3-nitrophenyl)-6-ethyl- |
0.016 |
Up |
SIRT2 |
7H-Pyrrolo[3,2-f]quinazoline-1,3-diamine, 7-[(4-aminophenyl)methyl]-, dihydrochloride |
0.027 |
Up |
SIRT2 |
ANTINEOPLASTIC-328785 |
0.045 |
Up |
SIRT2 |
5,5'-bis(2-methyl-1H-indol-3-yl)-3,3'-biisoxazole |
0.024 |
Down |
SIRT2 |
NSC 4271 |
0.029 |
Up |
SIRT2 |
C.I. 37559 |
0.049 |
Down |
SIRT2 |
RAPAMYCIN PRODRUG |
0.01 |
Down |
SIRT2 |
6H-Pyrido[4,3-b]carbazolium, 9-hydroxy-2,5,11-trimethyl-, (SP-4-1)-tetrachloroplatinate(2-) (2:1) |
0.041 |
Down |
SIRT2 |
ANTINEOPLASTIC-625543 |
0.036 |
Up |
SIRT2 |
NSC 639211 |
0.014 |
Down |
SIRT2 |
Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(4-methoxy- phenyl)methylene]-, hydrochloride |
0.045 |
Up |
SIRT2 |
Ethanedioic acid, mono(6-nitrobenzothiazol-2-yl)amide, mono[[2-(acetylhydrazino)-4-methylthiazol-5-yl]carbonyl] hydrazide |
0.043 |
Down |
SIRT2 |
23,27-Epoxy-3H-pyrido[2,1-c] [1,4]oxaazacyclohentriacontine-1,5,11,28,29-pentone-, 1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31, 32,33,34,34a-tetracosahydro- 27-hydroxy-10,21-dimethoxy-3-[2-[3-methoxy-4-[1-oxo- 3-(dimethylamino)propoxy]cyclohexy |
0.012 |
Down |
Expression pattern: Sensitivity / Resistance
Total:9 Current:2
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:69
Total:5 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:64
Total:5 Current:1
[First] [Prev]  Next Last 
|